Le Lézard
Classified in: Science and technology, Business
Subject: OFR

Veralto Begins Trading as Public Company


Spun off from Danaher and carrying a legacy of operational excellence, new business seeks growth by Safeguarding the World's Most Vital Resourcestm

WALTHAM, Mass., Oct. 2, 2023 /PRNewswire/ -- Today marked the first day of regular way trading for Veralto (NYSE: VLTO) as it begins its new journey as a publicly traded company.

Veralto separated from its former parent, Danaher Corporation, on September 30, 2023. Now, it is a separate, publicly traded company composed of 13 operating companies ? Aquatic Informatics, ChemTreat, Esko, Hach, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, X-Rite ? each a leading brand in its industry.

"At Veralto, we are driven by our purpose: Safeguarding the World's Most Vital Resources," said Jennifer L. Honeycutt, President and Chief Executive Officer of Veralto. "Billions of people around the world depend on our products and services to help make sure the water they drink, the food that they eat and the medicine they take are safe, and these critical needs drive not only our commitment to our customers, but also our ambition for long-term growth."

The operating companies of Veralto:

Veralto is organized into two segments:

The success of the Veralto operating companies is bolstered by the organization's use of the Veralto Enterprise System (VES), a derivative of the Danaher Business System (DBS). The tools and processes of DBS have been well researched and documented for driving operational excellence, and VES will carry through the key tenets of the system.

Jennifer L. Honeycutt and the Veralto Executive Team will commemorate the new public listing of the company by ringing the opening bell at the New York Stock Exchange on Monday, October 9, 2023.

About Veralto

With annual sales of nearly $5 billion, Veralto is a global leader in essential technology solutions with a proven track record of solving some of the most complex challenges we face as a society. Our industry-leading companies with globally recognized brands are building on a long-established legacy of innovation and customer trust to create a safer, cleaner, more vibrant future. Headquartered in Waltham, Massachusetts, our global team of 16,000 associates is committed to making an enduring positive impact on our world and united by a powerful purpose: Safeguarding the World's Most Vital Resourcestm.

Forward-Looking Statements

Statements in this release that are not strictly historical, including any statements regarding events or developments that we anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, those set forth in our SEC filings, including our registration statement on Form 10. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, Veralto does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

SOURCE Veralto


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: